Maykin Ho

Maykin brings more than 30 years of experience in the healthcare and finance industries. She is a retired partner of Goldman Sachs and Co., where she served as Advisory Director of Global Healthcare Investment Banking and Co-head of U.S. Healthcare for Global Investment Research. In addition to her current role at Qiming Venture Partners, she serves on the Board of Directors for Agios Pharmaceuticals, the Aaron Diamond AIDS Research Center and the Institute for Protein Innovation. Maykin holds a Ph.D. in microbiology and immunology and a B.S. in biology from the State University of New York, Downstate Medical Center. Maykin was a postdoctoral fellow at Harvard Medical School and is also a graduate of the Advanced Management Program at Duke University’s Fuqua School of Business. Maykin previously served on the Board of Directors for Parexel during the organization’s tenure as a public company and during its ownership by Pamplona Capital Management.